chr1_+_26517032
|
5.730
|
|
CD52
|
CD52 molecule
|
chr5_-_88215034
|
5.612
|
NM_001193350
NM_002397
|
MEF2C
|
myocyte enhancer factor 2C
|
chr1_+_26517045
|
5.294
|
|
CD52
|
CD52 molecule
|
chr1_-_31003260
|
5.272
|
NM_006762
|
LAPTM5
|
lysosomal protein transmembrane 5
|
chr1_-_111544784
|
5.256
|
NM_024901
|
DENND2D
|
DENN/MADD domain containing 2D
|
chr12_+_25096755
|
5.033
|
|
LRMP
|
lymphoid-restricted membrane protein
|
chr1_-_111544820
|
5.009
|
|
DENND2D
|
DENN/MADD domain containing 2D
|
chrX_+_48427103
|
4.727
|
NM_000377
|
WAS
|
Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
|
chr14_-_22354457
|
4.608
|
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
chr12_+_25096472
|
4.314
|
NM_006152
|
LRMP
|
lymphoid-restricted membrane protein
|
chr17_-_26665220
|
4.272
|
NM_006495
|
EVI2B
|
ecotropic viral integration site 2B
|
chr22_+_35586950
|
4.229
|
NM_000631
NM_013416
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
chr14_-_22354389
|
4.086
|
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
chr17_-_26665213
|
4.077
|
|
EVI2B
|
ecotropic viral integration site 2B
|
chr17_-_26665144
|
3.999
|
|
EVI2B
|
ecotropic viral integration site 2B
|
chr5_+_118719591
|
3.738
|
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8
|
chr1_+_111217314
|
3.694
|
|
CD53
|
CD53 molecule
|
chr1_+_111217244
|
3.663
|
NM_000560
|
CD53
|
CD53 molecule
|
chr17_-_26665194
|
3.643
|
|
EVI2B
|
ecotropic viral integration site 2B
|
chr12_-_51887266
|
3.565
|
NM_000889
|
ITGB7
|
integrin, beta 7
|
chr14_-_22354851
|
3.550
|
NM_001126105
NM_003982
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
chr2_+_143603439
|
3.536
|
|
ARHGAP15
|
Rho GTPase activating protein 15
|
chr2_+_143603368
|
3.499
|
NM_018460
|
ARHGAP15
|
Rho GTPase activating protein 15
|
chr14_-_22358752
|
3.495
|
NM_001126106
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
chr6_-_32268267
|
3.364
|
|
GPSM3
|
G-protein signaling modulator 3
|
chr22_-_35970230
|
3.153
|
NM_002872
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
chr5_-_88214720
|
3.086
|
|
MEF2C
|
myocyte enhancer factor 2C
|
chr1_+_172395277
|
3.081
|
|
RABGAP1L
|
RAB GTPase activating protein 1-like
|
chr1_-_31003181
|
3.053
|
|
LAPTM5
|
lysosomal protein transmembrane 5
|
chr1_+_159899528
|
3.041
|
NM_001002273
NM_001002274
NM_001002275
NM_001190828
NM_004001
|
FCGR2B
FCGR2C
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
chr17_-_31441390
|
3.037
|
NM_002983
|
CCL3
|
chemokine (C-C motif) ligand 3
|
chr10_-_121292139
|
3.032
|
NM_001005339
|
RGS10
|
regulator of G-protein signaling 10
|
chr1_-_181826292
|
2.999
|
NM_000433
NM_001190789
NM_001190794
|
NCF2
|
neutrophil cytosolic factor 2
|
chr16_-_87570716
|
2.945
|
NM_005187
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
chr22_-_35970133
|
2.899
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
chr3_-_16530132
|
2.879
|
NM_015150
|
RFTN1
|
raftlin, lipid raft linker 1
|
chr6_-_32268615
|
2.865
|
|
GPSM3
|
G-protein signaling modulator 3
|
chr6_-_33016561
|
2.856
|
NM_002118
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
chr12_-_51887318
|
2.809
|
|
ITGB7
|
integrin, beta 7
|
chr10_-_98021144
|
2.750
|
NM_001114094
NM_013314
|
BLNK
|
B-cell linker
|
chr18_-_50004770
|
2.734
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
chr19_-_7672978
|
2.699
|
NM_002002
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
chr6_+_31648071
|
2.679
|
NM_000595
|
LTA
|
lymphotoxin alpha (TNF superfamily, member 1)
|
chr7_+_68702252
|
2.640
|
|
AUTS2
|
autism susceptibility candidate 2
|
chr6_-_90178630
|
2.612
|
|
RRAGD
|
Ras-related GTP binding D
|
chr14_+_20319049
|
2.611
|
NM_005615
|
RNASE6
|
ribonuclease, RNase A family, k6
|
chr6_-_90178544
|
2.605
|
|
RRAGD
|
Ras-related GTP binding D
|
chr1_-_183210296
|
2.585
|
NM_052966
|
FAM129A
|
family with sequence similarity 129, member A
|
chr1_-_25128951
|
2.578
|
|
RUNX3
|
runt-related transcription factor 3
|
chr19_+_54530497
|
2.578
|
|
CD37
|
CD37 molecule
|
chr19_-_10311262
|
2.568
|
NM_002162
|
ICAM3
|
intercellular adhesion molecule 3
|
chr2_-_96174865
|
2.558
|
NM_004418
|
DUSP2
|
dual specificity phosphatase 2
|
chr12_+_6930815
|
2.550
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
chr2_+_68445821
|
2.540
|
NM_002664
|
PLEK
|
pleckstrin
|
chr1_-_181826086
|
2.414
|
|
NCF2
|
neutrophil cytosolic factor 2
|
chr7_+_114350144
|
2.406
|
|
MDFIC
|
MyoD family inhibitor domain containing
|
chr7_-_86686754
|
2.396
|
NM_024315
|
C7orf23
|
chromosome 7 open reading frame 23
|
chr15_+_79304694
|
2.385
|
NM_172217
|
IL16
|
interleukin 16 (lymphocyte chemoattractant factor)
|
chr19_-_43800374
|
2.376
|
NM_001042600
NM_007181
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
chr6_+_31647854
|
2.362
|
NM_001159740
|
LTA
|
lymphotoxin alpha (TNF superfamily, member 1)
|
chr1_-_183210155
|
2.344
|
|
FAM129A
|
family with sequence similarity 129, member A
|
chr5_+_49998677
|
2.338
|
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8
|
chr6_-_32605898
|
2.304
|
NM_002125
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
chr6_-_31658044
|
2.272
|
NM_002341
NM_009588
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
chr5_+_49998528
|
2.253
|
NM_001178056
NM_024615
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8
|
chr1_+_26516967
|
2.249
|
NM_001803
|
CD52
|
CD52 molecule
|
chr2_+_68445936
|
2.246
|
|
PLEK
|
pleckstrin
|
chr17_-_35975227
|
2.186
|
NM_001838
|
CCR7
|
chemokine (C-C motif) receptor 7
|
chr7_+_101715137
|
2.165
|
|
SH2B2
|
SH2B adaptor protein 2
|
chr3_-_15348811
|
2.147
|
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
chr7_+_101715110
|
2.135
|
NM_020979
|
SH2B2
|
SH2B adaptor protein 2
|
chrX_-_47374187
|
2.111
|
NM_001145252
|
CFP
|
complement factor properdin
|
chr6_-_90178685
|
2.095
|
NM_021244
|
RRAGD
|
Ras-related GTP binding D
|
chr8_+_56954953
|
2.092
|
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
|
chr12_+_6926014
|
2.091
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
chr22_+_21407066
|
2.063
|
|
|
|
chrX_-_47374647
|
2.042
|
NM_002621
|
CFP
|
complement factor properdin
|
chr15_+_72861767
|
2.032
|
|
CSK
|
c-src tyrosine kinase
|
chr4_-_25473528
|
2.015
|
NM_015187
|
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans)
|
chr8_+_56954899
|
2.015
|
NM_001111097
NM_002350
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
|
chr17_+_31455332
|
1.997
|
NM_002984
|
CCL4
|
chemokine (C-C motif) ligand 4
|
chr13_-_45654292
|
1.966
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
chr6_+_31651319
|
1.943
|
NM_000594
|
TNF
|
tumor necrosis factor
|
chr8_+_56954946
|
1.932
|
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
|
chr6_+_31690957
|
1.927
|
NM_004847
NM_001623
|
AIF1
|
allograft inflammatory factor 1
|
chr15_+_72861470
|
1.890
|
NM_001127190
NM_004383
|
CSK
|
c-src tyrosine kinase
|
chr1_-_158883666
|
1.882
|
NM_003037
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
chr3_-_15349086
|
1.878
|
NM_004844
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
chr10_-_27189898
|
1.876
|
|
ABI1
|
abl-interactor 1
|
chr11_-_60475558
|
1.870
|
NM_016582
|
SLC15A3
|
solute carrier family 15, member 3
|
chr3_-_122862447
|
1.868
|
NM_005335
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
chrX_-_118711088
|
1.865
|
|
SEPT6
|
septin 6
|
chr17_+_31562577
|
1.813
|
NM_207007
NM_001001435
|
CCL4L2
CCL4L1
|
chemokine (C-C motif) ligand 4-like 2
chemokine (C-C motif) ligand 4-like 1
|
chr12_+_53177806
|
1.778
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
chrX_-_70248022
|
1.761
|
NM_000206
|
IL2RG
|
interleukin 2 receptor, gamma
|
chr10_-_27189797
|
1.750
|
|
ABI1
|
abl-interactor 1
|
chr12_+_6930694
|
1.744
|
NM_002831
NM_080549
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
chr17_+_62804036
|
1.743
|
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1
|
chr17_+_31664143
|
1.705
|
NM_207007
NM_001001435
|
CCL4L2
CCL4L1
|
chemokine (C-C motif) ligand 4-like 2
chemokine (C-C motif) ligand 4-like 1
|
chr19_+_54530485
|
1.705
|
NM_001040031
NM_001774
|
CD37
|
CD37 molecule
|
chr11_-_58099884
|
1.697
|
NM_004811
|
LPXN
|
leupaxin
|
chr7_+_73826244
|
1.659
|
NM_000265
|
NCF1
NCF1B
NCF1C
|
neutrophil cytosolic factor 1
neutrophil cytosolic factor 1B pseudogene
neutrophil cytosolic factor 1C pseudogene
|
chrX_-_135577102
|
1.651
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
chr12_+_53177758
|
1.649
|
NM_005337
|
NCKAP1L
|
NCK-associated protein 1-like
|
chr12_+_53177789
|
1.645
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
chr19_+_54530546
|
1.633
|
|
CD37
|
CD37 molecule
|
chr19_+_54530512
|
1.632
|
|
CD37
|
CD37 molecule
|
chr1_+_32512298
|
1.627
|
NM_001042771
|
LCK
|
lymphocyte-specific protein tyrosine kinase
|
chr3_-_122862391
|
1.624
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
chr12_-_8656705
|
1.616
|
NM_020661
|
AICDA
|
activation-induced cytidine deaminase
|
chr7_-_120285364
|
1.607
|
NM_012338
|
TSPAN12
|
tetraspanin 12
|
chrX_-_15782803
|
1.600
|
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
chr12_-_50004172
|
1.592
|
NM_016293
|
BIN2
|
bridging integrator 2
|
chr1_+_234372454
|
1.586
|
NM_003272
|
GPR137B
|
G protein-coupled receptor 137B
|
chr9_+_92603894
|
1.583
|
|
SYK
|
spleen tyrosine kinase
|
chrX_+_48427137
|
1.579
|
|
WAS
|
Wiskott-Aldrich syndrome (eczema-thrombocytopenia)
|
chrX_-_78509367
|
1.572
|
|
ITM2A
|
integral membrane protein 2A
|
chr16_-_87244896
|
1.564
|
NM_000101
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
chr9_+_92603884
|
1.557
|
|
SYK
|
spleen tyrosine kinase
|
chr19_+_54530458
|
1.546
|
|
CD37
|
CD37 molecule
|
chr6_-_32920689
|
1.535
|
NM_004159
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)
|
chr11_+_128068982
|
1.531
|
NM_002017
|
FLI1
|
Friend leukemia virus integration 1
|
chrX_-_78509662
|
1.513
|
NM_001171581
NM_004867
|
ITM2A
|
integral membrane protein 2A
|
chr6_-_32920387
|
1.506
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)
|
chr4_-_105631915
|
1.500
|
NM_025212
|
CXXC4
|
CXXC finger protein 4
|
chr12_-_50004102
|
1.499
|
|
BIN2
|
bridging integrator 2
|
chr2_-_175207521
|
1.482
|
NM_003387
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
chrX_-_15783015
|
1.479
|
NM_003916
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
chr6_-_32659958
|
1.475
|
|
HLA-DRB1
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 1
major histocompatibility complex, class II, DR beta 5
|
chr6_+_12825818
|
1.470
|
NM_030948
|
PHACTR1
|
phosphatase and actin regulator 1
|
chr13_-_48005251
|
1.461
|
NM_001268
|
RCBTB2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
|
chr19_-_6432765
|
1.459
|
NM_024898
|
DENND1C
|
DENN/MADD domain containing 1C
|
chr1_-_205161821
|
1.438
|
NM_001193338
NM_001142473
NM_005449
|
FAIM3
|
Fas apoptotic inhibitory molecule 3
|
chr4_-_91979113
|
1.431
|
NM_183049
|
TMSL3
|
thymosin-like 3
|
chr9_+_92603920
|
1.425
|
|
SYK
|
spleen tyrosine kinase
|
chr13_-_48005186
|
1.420
|
|
RCBTB2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
|
chr7_-_37454933
|
1.408
|
NM_014800
|
ELMO1
|
engulfment and cell motility 1
|
chr10_+_26767698
|
1.407
|
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
|
chr21_-_45165302
|
1.405
|
NM_000211
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
chr6_-_154719560
|
1.405
|
NM_001130700
NM_015553
|
IPCEF1
|
interaction protein for cytohesin exchange factors 1
|
chr11_+_120828058
|
1.405
|
NM_003105
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
chr11_-_46099531
|
1.402
|
NM_001101802
NM_016621
|
PHF21A
|
PHD finger protein 21A
|
chr1_-_142535878
|
1.390
|
|
LOC100286793
FLJ39739
|
hypothetical LOC100286793
hypothetical FLJ39739
|
chr21_-_45165204
|
1.381
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
chr5_-_169657312
|
1.377
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
chr21_-_45165249
|
1.376
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
chr17_-_59363352
|
1.363
|
NM_000626
NM_001039933
NM_021602
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
chr19_-_60610971
|
1.356
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
chr1_-_27825178
|
1.347
|
NM_001042747
|
FGR
|
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog
|
chr3_+_48482625
|
1.345
|
|
TREX1
|
three prime repair exonuclease 1
|
chr5_-_169657395
|
1.343
|
NM_005565
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
chr7_-_99536214
|
1.342
|
NM_182776
|
MCM7
|
minichromosome maintenance complex component 7
|
chr6_-_137155295
|
1.342
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
chr9_-_125732005
|
1.341
|
NM_020946
NM_024820
|
DENND1A
|
DENN/MADD domain containing 1A
|
chr12_+_6930804
|
1.337
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
chr1_-_51198383
|
1.335
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
chr10_-_101680645
|
1.334
|
|
DNMBP
|
dynamin binding protein
|
chr5_-_169657360
|
1.324
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
chr1_+_26671488
|
1.319
|
NM_005517
|
HMGN2
|
high-mobility group nucleosomal binding domain 2
|
chr6_-_137155222
|
1.318
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
chr2_-_60634271
|
1.317
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
chr1_+_172395170
|
1.313
|
NM_014857
|
RABGAP1L
|
RAB GTPase activating protein 1-like
|
chr16_+_27320983
|
1.308
|
NM_181078
NM_181079
|
IL21R
|
interleukin 21 receptor
|
chr22_+_35639564
|
1.300
|
NM_000395
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
chr1_-_181871473
|
1.295
|
|
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa
|
chr6_-_26164478
|
1.293
|
NM_005319
|
HIST1H1C
|
histone cluster 1, H1c
|
chr11_-_66877519
|
1.287
|
NM_021173
|
POLD4
|
polymerase (DNA-directed), delta 4
|
chr6_-_32920167
|
1.287
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)
|
chr6_+_31691745
|
1.282
|
NM_032955
|
AIF1
|
allograft inflammatory factor 1
|
chrX_-_15782842
|
1.267
|
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
chr1_-_51198328
|
1.260
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
chr1_-_32574185
|
1.258
|
NM_023009
|
MARCKSL1
|
MARCKS-like 1
|
chr19_-_60610792
|
1.255
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
chr3_+_9809776
|
1.253
|
NM_001198780
|
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa
|
chr17_+_22982383
|
1.250
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
chr22_-_16637194
|
1.247
|
|
BID
|
BH3 interacting domain death agonist
|
chr1_-_166172901
|
1.246
|
NM_001143674
|
BRP44
|
brain protein 44
|
chr1_-_149004852
|
1.246
|
|
CTSS
|
cathepsin S
|
chr7_+_68701704
|
1.243
|
NM_001127231
NM_001127232
NM_015570
|
AUTS2
|
autism susceptibility candidate 2
|
chr11_-_66961709
|
1.240
|
NM_005608
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein
|
chr2_-_74259308
|
1.240
|
NM_018221
|
MOBKL1B
|
MOB1, Mps One Binder kinase activator-like 1B (yeast)
|
chr12_-_47605478
|
1.238
|
NM_001143782
NM_016594
|
FKBP11
|
FK506 binding protein 11, 19 kDa
|
chr22_-_16637221
|
1.237
|
|
BID
|
BH3 interacting domain death agonist
|
chr12_-_50004208
|
1.236
|
|
BIN2
|
bridging integrator 2
|
chr1_+_207995999
|
1.219
|
NM_025228
|
TRAF3IP3
|
TRAF3 interacting protein 3
|
chr6_-_32919751
|
1.218
|
NM_148919
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7)
|
chr9_+_127549437
|
1.201
|
NM_006195
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
chr22_-_16637160
|
1.198
|
|
BID
|
BH3 interacting domain death agonist
|
chr1_-_51198052
|
1.188
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
chr19_-_8548297
|
1.183
|
|
MYO1F
|
myosin IF
|
chrX_-_15782826
|
1.182
|
|
|
|
chr19_-_46550788
|
1.182
|
|
TGFB1
|
transforming growth factor, beta 1
|
chr9_-_35640852
|
1.177
|
NM_014450
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1
|
chr17_+_22982372
|
1.166
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
chr10_+_30763056
|
1.160
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
chr6_-_6265896
|
1.156
|
NM_000129
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
chr1_-_9052170
|
1.156
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
chr6_-_137154859
|
1.155
|
|
|
|
chr17_+_22982344
|
1.153
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
chr1_-_181871490
|
1.152
|
|
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa
|